Abstract
FDG PET plays an essential role in the diagnosis and treatment of patients with esophageal carcinoma. A 67-year-old man, who presented with dysphagia, fatigue, weakness, anorexia, anergia, and weight loss, underwent Tc-99m bone scan, CT, and FDG PET imaging. The bone scan and CT were consistent with a malignancy. Whole-body FDG PET demonstrated multiple metastases in various locations and helped the treating physicians to institute appropriate therapy. The identification of metastases by FDG PET is a critical component of the initial evaluation of a patient with esophageal carcinoma for the diagnosis and treatment of the primary malignancy and metastases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
